It has been shown that the PINT87aa peptide interacts with PAF1, keeps the PAF1 complex on the target gene promoter, and regulates the formation of the PAF1/Pol II complex, thus controlling its downstream effects in the progression of several cancer types, including glioblastoma, BC, HCC, and GC (79). The gene discussed is PAF1; the disease is glioblastoma.